백신 보조제 시장

This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.

Report Scope

This report provides an overview of the global vaccine adjuvants market. It includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, disease type, vaccine type, route of administration, application, and region. Based on product type, vaccine adjuvants are categorized into particulate-based adjuvants, emulsion adjuvants, saponin-based adjuvants, Toll-like receptor (TLR) agonists, and other adjuvants. Based on disease type, the market is categorized into infectious diseases, cancer, and other diseases. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.

The report highlights the key trends and challenges affecting the market, along with analysis and discussions regarding patents, clinical trials, and emerging technologies.

The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key companies in the global vaccine adjuvants market. A dedicated company profile section provides information on leading companies, including GSK Plc., CSL, Novavax, Croda International Plc., Dynavax Technologies Corp., Avanti Research, Desert King, InvivoGen, SEPPIC, and SPI Pharma.

Report Includes

• An analysis of the global markets for vaccine adjuvant compounds and systems used in human and veterinary vaccines production
• Analyses of the global market trends, with historic data from 2023 to 2025, estimates for 2026 and projections of CAGRs through 2031
• Estimates of the market size and revenue prospects for global market, accompanied by a market share analysis by product type, disease type, vaccine type, route of administration, application, and region
• Facts and figures pertaining to the market dynamics, recent technological advancements in diabetes management, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Review of emerging technologies, market applications, industry structure, and key initiatives in clinical sequencing
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Profiles of the leading global companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Market Definition
• Different Categories of Vaccine Adjuvants
• Role of Adjuvants in Different Vaccine Types
• Future of Vaccine Adjuvants
• Porter's Five Forces Analysis
• Threat of New Entrants (Low)
• Bargaining Power of Buyers (High)
• Bargaining Power of Suppliers (Moderate)
• Threat of Substitutes (Low)
• Level of Competitiveness (Moderate)
• Macroeconomic Factors Analysis
• Economic Growth and Healthcare Spending
• Rising Prevalence of Infectious and Chronic Diseases
• Regulatory Factors
• Technological Developments
• Impact of U.S. Tariff Laws on the Vaccine Adjuvants Market

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Essential Role of Adjuvants in Modern Vaccine Platforms
• Expansion of Global Immunization Programs and Vaccine Coverage
• Rising Veterinary Vaccination and Livestock Disease-Control Needs
• Technological Developments in Next-Generation Adjuvants
• Market Restraints
• High Regulatory and Clinical Validation Requirements
• Side Effects and Toxicity of Adjuvants
• Supply Chain Constraints for Specialized Adjuvant Components
• Market Opportunities
• Development of Advanced Combination and Precision Adjuvant Systems
• Expansion of Therapeutic and Cancer Vaccine Development
• Growth in the Companion Animal Market

Chapter 4 Regulatory Landscape

• Overview
• Regulations and Standards by Select Country or Region

Chapter 5 Emerging Technologies and Patent Analysis

• Overview
• Emerging Technologies
• Development of Precision Combination Adjuvant Systems
• Scalable and Synthetic Production of Advanced Adjuvants
• Nanostructured and Lipid-Based Delivery Platforms with Integrated Immunostimulation
• Clinical Trial Analysis
• Key Takeaways
• Clinical Trials Analysis by Type of Study
• Clinical Trials Analysis by Status
• Clinical Trials Analysis by Phase
• Patent Analysis
• Key Takeaways
• Patents, by Year
• By Top Applicant
• By Top Owner
• By Jurisdiction

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Vaccine Adjuvants Market, by Product Type
• Key Takeaways
• Particulate-Based Adjuvants
• Emulsion Adjuvants
• Saponin-Based Adjuvants
• TLR Agonists
• Other Adjuvants
• Vaccine Adjuvants Market, by Disease Type
• Key Takeaways
• Infectious Diseases
• Cancer
• Other Diseases
• Vaccine Adjuvants Market, by Vaccine Type
• Key Takeaways
• Human Vaccines
• Veterinary Vaccines
• Vaccine Adjuvants Market, by Application
• Key Takeaways
• Commercial Applications
• Research Applications
• Vaccine Adjuvants Market, by Route of Administration
• Key Takeaways
• Intramuscular
• Subcutaneous
• Intradermal
• Other Routes of Administration
• Geographic Breakdown
• Vaccine Adjuvants Market, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Global Market Shares of Leading Companies
• Strategic Analysis

Chapter 8 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• AVANTI RESEARCH
• CRODA INTERNATIONAL PLC
• CSL
• DESERT KING
• DYNAVAX TECHNOLOGIES CORP.
• GSK PLC
• INVIVOGEN
• NOVAVAX
• SEPPIC
• SPI PHARMA
• A Few Emerging Start-ups/Market Disruptors